Rohto Pharmaceutical Co (RPHCF) Price & Analysis

Compare

3 Followers

RPHCF Stock Chart & Stats

Day’s Range― - ―

52-Week Range$12.48 - $28.23

Previous CloseN/A

Volume5.49K

Average Volume (3M)0.00

Market Cap

$3.33B

Enterprise Value$538.09B

Total Cash (Recent Filing)$61.71B

Total Debt (Recent Filing)¥38.81B

Price to Earnings (P/E)16.0

Beta0.18

Next Earnings

Aug 12, 2025

EPS EstimateN/A

Last Dividend Ex-Date

Mar 28, 2025

Dividend Yield1.67%

Share Statistics

EPS (TTM)0.19

Shares Outstanding236,178,310

10 Day Avg. Volume0

30 Day Avg. Volume0

Financial Highlights & Ratios

PEG Ratio2.26

Price to Book (P/B)2.20

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

$19.04

Price Target Upside33.43% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering4

Rohto Pharmaceutical Co News

PremiumCompany Announcements

Rohto Pharmaceutical Announces Dividend Increase

9d ago

PremiumCompany Announcements

Rohto Pharmaceutical Reports Strong Sales Growth

14d ago

PremiumCompany Announcements

Rohto Pharmaceutical Unveils 2025-2035 Growth Strategy

15d ago

PremiumCompany Announcements

Rohto Pharmaceutical Reports FY2025 Financial Results with Increased Sales and Dividends

15d ago

PremiumPre-Earnings

RPHCF Earnings this Week: How Will it Perform?

17d ago

PremiumCompany Announcements

Rohto Pharmaceutical Announces Leadership Changes to Drive Future Growth

19d ago

PremiumCompany Announcements

Rohto Pharmaceutical Completes Strategic Share Repurchase

3M ago

PremiumCompany Announcements

Rohto Pharmaceutical Announces Terms for 2032 Convertible Bonds

3M ago

See All RPHCF News

See All News >

Financials

Income Statement >

Options Prices

Currently, No data available

---

Ownership Overview

―

Insiders

11.79% Mutual Funds

― Other Institutional Investors

83.35% Public Companies and

Individual Investors

Detailed Ownership Overview >

RPHCF FAQ

What was Rohto Pharmaceutical Co Ltd’s price range in the past 12 months?

Rohto Pharmaceutical Co Ltd lowest stock price was $12.48 and its highest was $28.23 in the past 12 months.

What is Rohto Pharmaceutical Co Ltd’s market cap?

Rohto Pharmaceutical Co Ltd’s market cap is $3.33B.

When is Rohto Pharmaceutical Co Ltd’s upcoming earnings report date?

Rohto Pharmaceutical Co Ltd’s upcoming earnings report date is Aug 12, 2025 which is in 76 days.

How were Rohto Pharmaceutical Co Ltd’s earnings last quarter?

Rohto Pharmaceutical Co Ltd released its earnings results on May 13, 2025. The company reported $0.191 earnings per share for the quarter, beating the consensus estimate of $0.174 by $0.017.

Is Rohto Pharmaceutical Co Ltd overvalued?

According to Wall Street analysts Rohto Pharmaceutical Co Ltd’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Rohto Pharmaceutical Co Ltd pay dividends?

Rohto Pharmaceutical Co Ltd pays a Annually dividend of $0.119 which represents an annual dividend yield of 1.67%. See more information on Rohto Pharmaceutical Co Ltd dividends here

What is Rohto Pharmaceutical Co Ltd’s EPS estimate?

Rohto Pharmaceutical Co Ltd’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Rohto Pharmaceutical Co Ltd have?

Rohto Pharmaceutical Co Ltd has 236,178,310 shares outstanding.

What happened to Rohto Pharmaceutical Co Ltd’s price movement after its last earnings report?

Rohto Pharmaceutical Co Ltd reported an EPS of $0.191 in its last earnings report, beating expectations of $0.174. Following the earnings report the stock price went up 0.796%.

Which hedge fund is a major shareholder of Rohto Pharmaceutical Co Ltd?

Currently, no hedge funds are holding shares in RPHCF

Company Description

Rohto Pharmaceutical Co Ltd

Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams. It also offers medicine and medicated products for skin; medicine for internal use, such as digestive and herbal medicines; oral medicines comprising gastrointestinal medicines, herbal medicines, and supplements; non-prescription medicines; and beauty counters that provide beauty and health services. The company was formerly known as Yamada Pharmaceutical and changed its name to Rohto Pharmaceutical Co.,Ltd. in September 1949. Rohto Pharmaceutical Co.,Ltd. was founded in 1899 and is headquartered in Osaka, Japan.

RPHCF Stock 12 Month Forecast

Average Price Target

$19.04

▲(33.43%Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"12":"$12","27":"$27","15.75":"$15.75","19.5":"$19.5","23.25":"$23.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":22.761,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$22.76</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":19.04,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$19.04</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":13.69875,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$13.70</span>\n  </div></div>","useHTML":true}}],"tickPositions":[12,15.75,19.5,23.25,27],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2021","6":"Sep<br/>2023","9":"Nov<br/>2024","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,16.63,17.101615384615382,17.57323076923077,18.04484615384615,18.516461538461538,18.98807692307692,19.459692307692308,19.93130769230769,20.402923076923077,20.87453846153846,21.346153846153847,21.81776923076923,22.289384615384613,{"y":22.761,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,16.63,16.815384615384616,17.00076923076923,17.186153846153847,17.37153846153846,17.556923076923077,17.74230769230769,17.927692307692308,18.11307692307692,18.298461538461538,18.48384615384615,18.66923076923077,18.854615384615386,{"y":19.04,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,16.63,16.40451923076923,16.17903846153846,15.953557692307692,15.728076923076923,15.502596153846154,15.277115384615385,15.051634615384614,14.826153846153845,14.600673076923076,14.375192307692307,14.149711538461538,13.92423076923077,{"y":13.69875,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":14.47,"date":1622505600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":14.47,"date":1625097600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":14.47,"date":1627776000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":14.47,"date":1630454400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":14.89,"date":1633046400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":14.89,"date":1633046400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.36,"date":1693526400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.61,"date":1701388800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.02,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.68,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.24,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.04,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.63,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >